Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development Post author: Post published:June 17, 2024 Post category:uncategorized Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays. You Might Also Like How 196,000 Spanish participants are helping decode heart disease risk May 14, 2025 Listen: NPR and KFF Health News explore how racism and violence hurt health January 6, 2025 Overdosing on chemo: A common gene test could save hundreds of lives each year March 26, 2024